These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 23761054)

  • 41. Spatially controlled coating of continuous liquid interface production microneedles for transdermal protein delivery.
    Caudill CL; Perry JL; Tian S; Luft JC; DeSimone JM
    J Control Release; 2018 Aug; 284():122-132. PubMed ID: 29894710
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fabrication, characterization and application of sugar microneedles for transdermal drug delivery.
    Nguyen HX; Banga AK
    Ther Deliv; 2017 Mar; 8(5):249-264. PubMed ID: 28361607
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Use of a Pressure-Indicating Sensor Film to Provide Feedback upon Hydrogel-Forming Microneedle Array Self-Application In Vivo.
    Vicente-Pérez EM; Quinn HL; McAlister E; O'Neill S; Hanna LA; Barry JG; Donnelly RF
    Pharm Res; 2016 Dec; 33(12):3072-3080. PubMed ID: 27633885
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Challenges and strategies in developing microneedle patches for transdermal delivery of protein and peptide therapeutics.
    Wu F; Yang S; Yuan W; Jin T
    Curr Pharm Biotechnol; 2012 Jun; 13(7):1292-8. PubMed ID: 22201589
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Microneedles for transdermal drug delivery: a minireview.
    Vandervoort J; Ludwig A
    Front Biosci; 2008 Jan; 13():1711-5. PubMed ID: 17981662
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Combined use of biocompatible nanoemulsions and solid microneedles to improve transport of a model NSAID across the skin: In vitro and in vivo studies.
    Ilić T; Savić S; Batinić B; Marković B; Schmidberger M; Lunter D; Savić M; Savić S
    Eur J Pharm Sci; 2018 Dec; 125():110-119. PubMed ID: 30287408
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vitro permeation of a pegylated naltrexone prodrug across microneedle-treated skin.
    Milewski M; Yerramreddy TR; Ghosh P; Crooks PA; Stinchcomb AL
    J Control Release; 2010 Aug; 146(1):37-44. PubMed ID: 20678989
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Qualitative and quantitative analysis of lateral diffusion of drugs in human skin.
    Nguyen HX; Puri A; Bhattaccharjee SA; Banga AK
    Int J Pharm; 2018 Jun; 544(1):62-74. PubMed ID: 29654897
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transdermal Delivery of Iron Using Soluble Microneedles: Dermal Kinetics and Safety.
    Modepalli N; Shivakumar HN; McCrudden MT; Donnelly RF; Banga A; Murthy SN
    J Pharm Sci; 2016 Mar; 105(3):1196-200. PubMed ID: 26928401
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Facial skin barrier function recovery after microneedle transdermal delivery treatment.
    Han TY; Park KY; Ahn JY; Kim SW; Jung HJ; Kim BJ
    Dermatol Surg; 2012 Nov; 38(11):1816-22. PubMed ID: 22882208
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transdermal delivery of insulin using microneedles in vivo.
    Martanto W; Davis SP; Holiday NR; Wang J; Gill HS; Prausnitz MR
    Pharm Res; 2004 Jun; 21(6):947-52. PubMed ID: 15212158
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Controllable coating of microneedles for transdermal drug delivery.
    Chen J; Qiu Y; Zhang S; Yang G; Gao Y
    Drug Dev Ind Pharm; 2015 Mar; 41(3):415-22. PubMed ID: 24378200
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Non-Ablative Fractional Laser to Facilitate Transdermal Delivery.
    Ganti SS; Banga AK
    J Pharm Sci; 2016 Nov; 105(11):3324-3332. PubMed ID: 27624669
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ex vivo transdermal absorption of a liposome formulation of diclofenac.
    Sacha M; Faucon L; Hamon E; Ly I; Haltner-Ukomadu E
    Biomed Pharmacother; 2019 Mar; 111():785-790. PubMed ID: 30612003
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Microneedle-Assisted Percutaneous Transport of Magnesium Sulfate.
    Ghimirey KB; Ita K
    Curr Drug Deliv; 2020; 17(2):140-147. PubMed ID: 31845631
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A new paradigm for numerical simulation of microneedle-based drug delivery aided by histology of microneedle-pierced skin.
    Han T; Das DB
    J Pharm Sci; 2015 Jun; 104(6):1993-2007. PubMed ID: 25821048
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Microneedle delivery: clinical studies and emerging medical applications.
    Pettis RJ; Harvey AJ
    Ther Deliv; 2012 Mar; 3(3):357-71. PubMed ID: 22833995
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Optimizing microneedle arrays for transdermal drug delivery: extension to non-square distribution of microneedles.
    Al-Qallaf B; Das DB
    J Drug Target; 2009 Feb; 17(2):108-22. PubMed ID: 19016071
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development of Hydrogels for Microneedle-Assisted Transdermal Delivery of Naloxone for Opioid-Induced Pruritus.
    Gao X; Brogden NK
    J Pharm Sci; 2019 Nov; 108(11):3695-3703. PubMed ID: 31476312
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Microneedle-based drug delivery: studies on delivery parameters and biocompatibility.
    Wu Y; Qiu Y; Zhang S; Qin G; Gao Y
    Biomed Microdevices; 2008 Oct; 10(5):601-10. PubMed ID: 18324474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.